27 Facts About Merck KGaA

Merck KGaA is divided into three business lines: Healthcare, Life Sciences and Electronics.

Merck KGaA was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies in the world.

Merck KGaA operates in Europe, Africa, Asia, Oceania and the Americas.

Merck KGaA pioneered the commercial manufacture of morphine in the 19th century and for a time held a virtual monopoly on cocaine.

Merck KGaA was privately owned until going public on the Frankfurt Stock Exchange in 1995 and is listed on the DAX index of Germany's top companies.

Related searches

The Merck Group includes around 250 companies in 180 countries; the current main parent company of the group, since 1995, is named Merck KGaA, and is itself mainly owned by the former main parent company, E Merck oHG, which now operates as a holding company.

In 2015 Merck KGaA adopted a uniform brand identity for all its subsidiaries, and the company has stressed its intention to protect the brand of "the real Merck KGaA" globally and initiated litigation against its former subsidiary over use of the name.

Merck KGaA has formed a strategic alliance with the Technische Universitat Darmstadt, which is located in the same town as Merck KGaA.

Roots of Merck KGaA reach back as far as the 17th century in the Landgraviate of Hesse-Darmstadt .

Merck KGaA began the manufacture of these substances "in bulk" in 1827, touting them as a "Cabinet of Pharmaceutical and Chemical Innovations".

Merck KGaA established its philanthropic foundation in 2008 called Merck Foundation and Rasha Kelej currently serves as its CEO.

In 2010, Merck KGaA took over Billerica based Millipore Corporation for EUR 5.

Merck KGaA Korea received the "Leading Investor Award" at the 5th Korea-EU Industrial Cooperation Day in 2011.

In October 2015, Merck KGaA revealed it would return the rights of the Kuvan drug to BioMarin Pharmaceutical Inc The drug is effective in the treatment of the rare genetic disorder PKU, however Merck KGaA is moving away from genetics into cancer treatment, immunology and neurology.

In February 2020, Merck KGaA announced the divestment of its Allergopharma Business to Dermapharm, under an unspecified fee.

In September 2017, Merck KGaA said it is considering options for its consumer-health division, including a potential full or partial sale, or strategic partnership.

Merck in Darmstadt is the sole legal successor of the original Merck and retains the rights to the trademark "Merck" in all countries except the U S and Canada, where "EMD" brand is mostly used .

Merck KGaA was legally known as E Merck oHG until 1995, when Merck KGaA became the main parent company and the former a holding company.

In 2015 Merck KGaA adopted a new logo to increase the visual differences between both companies, while visualizing “vibrant science and technology” as the new company's brand.

From 1884 onwards, Merck KGaA played role in the production and marketing of cocaine.

For Merck KGaA, this meant two-digit sales-growth figures for many years.

Some products from Merck KGaA include Metformin, Bisoprolol, Levothyroxine and Digitoxin.

In February 2019, Merck KGaA announced a partnership with GSK to develop and commercialize M7824, a new Immunotherapy with potential in various difficult-to-treat cancers.

Life science business of Merck KGaA, formerly known as Merck KGaA Millipore, was created in July 2010 following the completed acquisition of the US company Millipore.

Merck KGaA Millipore had three business units: Bioscience, Lab Solutions and Process Solutions.

Related searches

In 2015, Merck KGaA acquired SigmaAldrich and combined it with Merck KGaA Millipore.

Merck KGaA serves customers in biotech, pharma, diagnostics, food safety, academia, and environmental.